Baxano Surgical has announced that the first case utilising the Avance minimally invasive pedicle screw system was recently performed by Sameer Mathur in Cary, North Carolina, USA. The innovative design of Avance provides for an easy-to-use, percutaneous pedicle screw system that addresses single, complex and multi-level spinal pathologies with minimal tissue disruption and trauma. The Avance system will be in limited market release through the end of third quarter of 2014 and is planned for full launch in the fourth quarter of 2014.
“The first clinical use of the Avance pedicle screw system represents a major milestone in the evolution of Baxano Surgical,” states Ken Reali, president and chief executive officer of Baxano Surgical. “Avance will significantly enhance our ability to service our surgeon customers’ lower lumbar fusion needs where we can now offer a complete fusion solution coupled with our AxiaLIF and VEO interbody fusion implants. This is an important strategic initiative that increases our presence in the rapidly growing minimally invasive spine arena.”
“The Avance system provides a step forward with a true minimally invasive approach to spinal fixation by minimising tissue trauma and eliminating additional rod insertion incisions,” states spine surgeon Sameer Mathur. “The system’s low-profile design, combined with Avance’s intraoperative flexibility and range of options to meet surgeon preferences makes for a durable, versatile, easy-to-use solution.”
According to Baxano Surgical, the Avance minimally invasive pedicle screw system is intended for posterior, non-cervical pedicle fixation of the spine to provide immobilisation and stabilisation of spinal segments in skeletally-mature patients as an adjunct to fusion for the following indications: degenerative disc disease, spondylolisthesis, trauma, spinal stenosis, curvatures, tumour, pseudoarthrosis and failed previous fusion. The Avance system accommodates single level degenerative procedures as well as multi-level, complex pathologies from T1 to S1.